Multivalve disease: defining pathways for optimal assessment and treatment in the absence of good clinical evidence
Tutorial
Main Arena
Anchorperson: Alec Vahanian
Spokesperson: Anita Asgar
Discussants: Madalina Garbi, Jörg Hausleiter, Raj Makkar, David Messika-Zeitoun, Tiffany Patterson, Gilbert Tang
Watch this session if you want
- To appreciate the frequency of multivalve disease and its association with poor clinical outcomes
- To understand the need for comprehensive multimodality investigation, including assessment of the pulmonary circulation and right ventricular function
- To learn how to identify high risk patients and instigate measures that will ensure best clinical outcomes
Welcome and session objectives
Alec Vahanian
Modern means of multi-modality assessment: advanced echocardiography, magnetic resonance or cardiac catheterisation?
Joao Cavalcante
Discussion and audience interaction
Cardiopulmonary interaction: the impact of the pulmonary circulation and right ventricular function
Philipp Lurz
Discussion and audience interaction
High risk combinations: measures for haemodynamic support and the role of procedural sequencing
Marianna Adamo
Discussion and audience interaction
Session evaluation and key learnings
Anita Asgar
Suggested videos
8:13
